|
Volumn 36, Issue 1, 2000, Pages 7-9
|
The treatment of ovarian cancer has reached new standards of care
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CARBOPLATIN;
CISPLATIN;
CYCLOPHOSPHAMIDE;
EPIRUBICIN;
GEMCITABINE;
MITOXANTRONE;
OXALIPLATIN;
PACLITAXEL;
TOPOTECAN;
ANTINEOPLASTIC ACTIVITY;
BONE MARROW SUPPRESSION;
CANCER SURVIVAL;
DRUG EFFICACY;
HUMAN;
NEUROTOXICITY;
NOTE;
OVARY CANCER;
PRIORITY JOURNAL;
RELAPSE;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CISPLATIN;
FEMALE;
HUMANS;
OVARIAN NEOPLASMS;
PACLITAXEL;
QUALITY OF HEALTH CARE;
|
EID: 0033981559
PISSN: 09598049
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
Times cited : (2)
|
References (19)
|